Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Africa Pathogen Genomics Initiative (Africa PGI) $100 million four-year initiative will rapidly expand access to next-generation genomic sequencing tools and strengthen public health surveillance networks across Africa Oxford […]
Licenses aim to accelerate drug discovery leading to development of new therapies PanCELLa agreement marks MilliporeSigma’s first CRISPR license for bioproduction Takara Bio USA agreement gives access to MilliporeSigma’s CRISPR integration and vector technologies for Takara’s vector products and cell engineering services MilliporeSigma today announced that it has signed agreements licensing its CRISPR technology to two […]
Joins Africa CDC alongside the Bill & Melinda Gates Foundation and others in a four-year plan October 12, 2020 A dangerous novel pathogen emerging in any region is devastating, but even more so when genomics and bioinformatics infrastructure is insufficient to identify, monitor, or slow its spread. In resource-limited environments, public health officials struggle to allocate […]
LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized device, MinION Mk1C. Following an application to the UK’s MHRA, the LamPORE assay is now CE marked for in vitro diagnostic use for […]
OXFORD, England –– LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized device, MinION Mk1C. Following an application to the UK’s MHRA, the LamPORE assay is now CE marked for in vitro […]
ANN ARBOR, MI—The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. Tauopathies are a group of neurodegenerative disorders sharing a common pathology […]
Expanded testing for toxins generated by harmful algal blooms in freshwater and shellfish to reduce testing burden on the aquaculture industry and improve the safety of the nation’s water and food supply. BOULDER, CO – MBio Diagnostics today announced receipt of two three-year NOAA/NCCOS PCMHAB awards for test menu expansion of its HAB Toxin System. […]
MILAN (Italy) and MADISON (Wis., USA) –Axxam S.p.A., a leading provider of integrated drug discovery services across life sciences industries, and FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of human induced pluripotent stem cell (hiPSC) models and therapies, announce a strategic alliance to improve the drug discovery process. The alliance will provide drug […]
SAN DIEGO — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Spike recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic. Since the emergence of the COVID-19 outbreak, Exonbio has developed a comprehensive portfolio of SARS-CoV-2 recombinant rabbit antibodies using its proprietary Single Plasma cell INterrogation (SPIN®) platform. Exonbio […]
BRANFORD, Conn. — Isoplexis, the leader in single-cell functional proteomics, today announced a partnership with Yale University to use IsoPlexis’ functional immune landscaping and high-plex automated immunoassay solutions to identify various predictive markers of immune response to COVID-19. The lead investigators at Yale University include Dr. Rong Fan, a professor of Biomedical Engineering at Yale whose focus includes single-cell analysis of human diseases to help transform the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
